Emami Limited

Sector: FMCG — Personal Care & Healthcare  |  HQ: Kolkata, West Bengal  |  Founded: 1974  |  Employees: ~6,000+

Listed as: NSE / BSE listed (EMAMILTD.NS)  |  NSE / BSE  |  Ticker: EMAMILTD.NS  |  Website →

Company overview

Emami Limited is a leading Indian FMCG company founded in 1974, specializing in ayurvedic and herbal personal care, healthcare, and wellness products. Key brands include Fair & Handsome (men's grooming), Boro Plus (antiseptic cream), Kesh King and Navratna (hair oils), and Zandu (digestive and pain relief ayurvedic products). The company holds significant market share in India's rural and semi-urban beauty and wellness segments.

Recent developments

March–May 2026

Emami continues to aggressively expand its digital and direct-to-consumer (D2C) footprint, completing a 60% acquisition of IncNut Digital—the parent company of Vedix and SkinKraft—for ₹321 crore [4][7]. This move supports the company's D2C pivot amid flat full-year revenues of ₹3,780 crore [3]. Concurrently, the company hired Dhruv Aggarwal as Chief Growth Officer to accelerate growth initiatives [8].

On the financial front, Q4 advertising spend increased 12% year-over-year, with full-year ad spends up 6.5%, indicating continued investment in brand marketing [2]. Management is targeting ₹2,000 crore revenue from HoReCa and foodservice channels [9], and senior leadership is scheduled to present at the 360 ONE Capital Investor Conference in late May [10]. The company also declared a total ₹10 dividend [3] while navigating summer sales headwinds tied to Middle East tensions affecting its domestic portfolio [1].

Sources (8)

1. Emami's desi portfolio puts up a fight as summer sales melt amid West Asia tensions - The Economic Times · The Economic Times · Thu, 21 May 2026
2. Emami Q4 ad spends rise 12% YoY; full year spends up 6.5% - bestmediainfo.com · bestmediainfo.com · Thu, 21 May 2026
3. Emami Limited Revenue Flat at ₹3,780 Cr; Declares Total ₹10 Dividend Amid D2C Pivot - Trade Brains · Trade Brains · Thu, 21 May 2026
4. Emami to acquire 60% stake in IncNut Digital for Rs 321 crore - The Times of India · The Times of India · Fri, 08 May 2026
5. Emami acquires 60% stake in Vedix, SkinKraft parent IncNut Digital for ₹321 crore - Fortune India · Fortune India · Thu, 07 May 2026
6. Emami appoints Dhruv Aggarwal as Chief Growth Officer - Storyboard18 · Storyboard18 · Fri, 27 Mar 2026
7. Emami Targets INR 2,000 Crore from HoReCa & Foodservices - Entrepreneur India · Entrepreneur India · Wed, 11 Mar 2026
8. Emami Senior Management to Participate in 360 ONE Capital 16th Annual Investor Conference on May 28, 2026 - scanx.trade · scanx.trade · Wed, 13 May 2026

Financial performance and recent trajectory

Disclosed revenue (FY25): Not separately disclosed in segment-wise FY 2024-25 reporting.

12-month price trajectory

Monthly closes over the last 12 months. Source: Yahoo Finance.

Competitive position

Emami competes with Hindustan Unilever (Hindustan Unilever Ltd), Procter & Gamble (P&G India), Colgate-Palmolive India, and Godrej Consumer Products in the personal care space, positioning itself as a mass-market ayurvedic-herbal alternative at accessible price points across Tier-2, Tier-3, and rural markets.

Key risks

Rising raw material costs (edible oils, herbs) squeeze margins amid competitive pricing pressure Heavy reliance on the hair oil and fairness cream categories, which face shifting consumer preferences Intense competition from multinational FMCG giants with larger marketing budgets Regulatory scrutiny and potential bans/restrictions on certain product claims or ingredients

Outlook

Emami is a participant in the Indian cosmetics & personal care plant category, which forms part of the broader Manufacturing space. The Indian cosmetics & personal care plant market continues to evolve with rising organised share, premiumisation, distribution expansion, and a regulatory architecture covering the Companies Act 2013, the Income Tax Act 1961, the CGST Act 2017, the Legal Metrology Act 2009, and sectoral statutes including the Food Safety and Standards Act 2006 (for food and beverage subsegments), the Drugs and Cosmetics Act 1940 (for pharmaceutical or healthcare adjacencies), the Environment Protection Act 1986 (for emissions and effluents), and labour codes consolidated under the four 2020 labour codes. In KAMRIT's project report framework for this category, the competitive set typically includes pan-India branded leaders, multinational subsidiaries, mid-sized regional players, and a long tail of MSME participants. The structural attractiveness of the category for new entrants is a function of (a) market growth rate, (b) the share that remains with unorganised or fragmented operators, (c) the cost of regulatory compliance, and (d) the capex intensity of plant and machinery. The KAMRIT bankable DPR for this category structures a new entrant's economics against this competitive landscape. For Emami specifically, public-domain disclosures provide a baseline view of operations, but segment-wise revenue, EBITDA, capacity utilisation, and forward capex plans are not separately broken out in many cases. Where the company is part of a listed group, the SEBI LODR and the Companies Act 2013 governance framework apply, with statutory audit conducted under SA 700 and CARO 2020 reporting. Where the company is unlisted, the Companies Act 2013 framework continues to govern with reduced public disclosure. The risk and opportunity outlook for Emami mirrors the broader cosmetics & personal care plant category dynamics. Demand-side drivers include rising household consumption, urbanisation, organised retail expansion, and policy support including PLI schemes (where applicable to the segment). Supply-side risks include input cost volatility, regulatory tightening, environmental compliance escalation, and competitive intensity from larger groups or imports. Management quality, balance sheet strength, distribution depth, and the capex execution track record are the differentiators within the peer set. KAMRIT's research desk maintains a baseline reference for Emami as a peer benchmark within the cosmetics & personal care plant category. For investors, lenders, or new entrant promoters seeking a fuller assessment of Emami, KAMRIT's deep-dive company profile engagement covers financial trajectory, capacity and capex, distribution and customer concentration, regulatory exposure, and the competitive position with named peers.

KAMRIT point of view

Building or competing with Emami?

KAMRIT advises promoters, family offices, and global enterprises evaluating greenfield entry into the fmcg — personal care & healthcare sector. Our Bankable DPR with Cost Model and ROI benchmarks your project economics against the listed-company cost structure of Emami and peers. The Execution Partnership tier covers everything from incorporation through commissioning. A 20-minute scoping call with our partners is free.

Book a scoping call

Disclaimer: This profile is compiled by KAMRIT Financial Services LLP for educational and benchmarking purposes only. It is not investment advice, a recommendation to buy or sell securities, or a solicitation. Stock data is provided by Yahoo Finance and may be delayed by up to 20 minutes. Company financial commentary draws on publicly available filings, exchange disclosures, and KAMRIT industry research. Readers should consult a SEBI-registered investment adviser before making investment decisions. KAMRIT is a financial services and compliance firm, not a SEBI-registered investment adviser.